Session Information
-
WCLC 2019
2019 World Conference on Lung Cancer
Conference Program for the 2019 World Conference on Lung Cancer in Barcelona, Spain
Presentation Date(s):- Sept 7 - 10, 2019
- Total Presentations: 2970
September 7 Sat
Sep 7 Sunday
September 8 Sun
Sep 8 Monday
September 9 Mon
Sep 9 Tuesday
September 10 Tue
Sep 10
-
+
MA06 - Challenges in the Treatment of Early Stage NSCLC
- 13:30 - 15:00
- 9/08/2019
- Location: Colorado Springs (1994)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Treatment of Early Stage/Localized Disease
- Moderators:Florentino Hernando-Trancho, Ayten Kayi Cangir
-
+
MA06.06 - A Phase III Study of Adjuvant Chemotherapy in Patients with Completely Resected, Node-Negative Non-Small Cell Lung Cancer
14:00 - 14:05 | Presenter: Hideo Kunitoh | Author(s): Hiroyuki Sakurai, Masahiro Tsuboi, Masashi Wakabayashi, Morihito Okada, Kenji Suzuki, Norihiko Ikeda, Makoto Takahama, Mitsuhiro Takenoyama, Yasuhisa Ohde, Katsuo Yoshiya, Isao Matsumoto, Motohiro Yamashita, Takashi Marutsuka, Hiroshi Date, Toru Hasumi, Yoshinori Yamashita, Norihito Okumura, Shun-ichi Watanabe, Hisao Asamura
- Abstract
Loading...
-
+
P1.17 - Treatment of Early Stage/Localized Disease
- 09:45 - 18:00
- 9/08/2019
- Location: Exhibit Hall
- Type: Poster Viewing in the Exhibit Hall
- Track: Treatment of Early Stage/Localized Disease
-
+
P1.17-04 - Multicenter Observational Study of Node-Negative Non-Small Cell Lung Cancer Patients Who Are Excluded from a Clinical Trial
09:45 - 09:45 | Presenter: Hiroyuki Sakurai | Author(s): Yasushi Goto, Kiyotaka Yoh, Kazuya Takamochi, Takehito Shukuya, Tomoyuki Hishida, Masahiro Tsuboi, Koichi Yoshida, Yasuhisa Ohde, Sakae Okumura, Yasuo Ohashi, Hideo Kunitoh
- Abstract
Loading...
-
+
ES21 - Current Strategies to Improve Outcome of Patients with Oligometastatic NSCLC
- 15:45 - 17:15
- 9/09/2019
- Location: Dublin (1997)
- IASLC CME Accredited
- Type: Educational Session
- Track: Oligometastatic NSCLC
- Moderators:Ernest Nadal, Francoise Mornex
-
+
ES21.04 - Optimal Systemic Treatment of OMD
16:30 - 16:45 | Presenter: Hideo Kunitoh
- Abstract
Loading...
-
+
MA21 - Non EGFR/MET Targeted Therapies
- 14:30 - 16:00
- 9/10/2019
- Location: Vienna (2016)
- IASLC CME Accredited
- Type: Mini Oral Session
- Track: Targeted Therapy
- Moderators:Benjamin Besse, Michael Thomas
-
+
MA21.11 - A Multicenter Phase II Study of Low-Dose Erlotinib in Frail Patients with EGFR Mutation-Positive, Non-Small Cell Lung Cancer: TORG1425
15:40 - 15:45 | Presenter: Sakiko Otani | Author(s): Kazuhiko Yamada, Shingo Miyamoto, Koichi Azuma, Hidenobu Ishii, Akihiro Bessho, Shinobu Hosokawa, Hideo Kunitoh, Kazuhito Miyazaki, Hiroshi Tanaka, Satoru Miura, Hiromi Aono, Yoshiro Nakahara, Kei Kusaka, Yukio Hosomi, Akinobu Hamada, Hiroaki Okamoto
- Abstract
Loading...